The drug design is based on molecular modeling studies performed by the internal computational unit. We employ procedures for the microwave-assisted synthesis and highly automated purifications developed inside the reearch unit. We have developed reasearch projects of antiviral agents (novel classes of HIV NNRTI classes: IAS, PAS, PBTD, DAMNI), antifungal agents (analogues of bifonazole (Ph.D.